Associations
newsletter
subscribe
advertise
contact
Technology
pulseTV
Buyer's Guide
Comparison Charts
Blogs
Events
Webinars
Magazine
Cardiac Diagnostics
ECG
ECG Management Systems
Holter Monitoring Systems
Stress Test Systems
Cardiac Imaging
Advanced Visualization
Angiography Systems
Cardiovascular Ultrasound
Contrast Media
CT Systems
Hybrid OR
MRI Systems
Nuclear Imaging
Cath Lab
Angiography Systems
Balloon Catheters
Hemostasis Management
Intravascular Imaging Systems
Interventional Radiology
Hybrid OR
Radial Access
Stents
Ventricular Assist Devices (VAD)
EP Lab
Ablation Systems
Cardiac Resynchronization Therapy Devices (CRT)
Implantable Cardioverter Defibrillators (ICD)
Leads, implantable devices
Pacemakers
Information Technology
Advanced Visualization
Cardiac PACS
Telecardiology
Structural Heart
Heart Valve Repair
Hybrid OR
Left Atrial Appendage (LAA) Occluders
Structural Heart Occluders/Closure Devices
Johnson and Johnson
Related Articles
Antiplatelet Therapy
U.K. Clears Rivaroxaban as First Fixed Dose, Once-Daily Anticoagulant Tablet for Stroke, AF, DVT
Rivaroxaban Used in Combination with Standard Therapy Reduced Cardiovascular Death
Pharmaceuticals
U.K. Clears Rivaroxaban as First Fixed Dose, Once-Daily Anticoagulant Tablet for Stroke, AF, DVT
Rivaroxaban Significantly Reduces Stroke Risk in AF Patients
Cardiology Related
Rivaroxaban Used in Combination with Standard Therapy Reduced Cardiovascular Death
Heart Failure Treatments
Rivaroxaban Used in Combination with Standard Therapy Reduced Cardiovascular Death
Clinical Trial/Study
Rivaroxaban Used in Combination with Standard Therapy Reduced Cardiovascular Death
Rivaroxaban Significantly Reduces Stroke Risk in AF Patients
Stents
Cordis Discontinues Cypher Stent, Halts Development of Nevo Stent
Stents, Drug Eluting
Cordis Discontinues Cypher Stent, Halts Development of Nevo Stent
Stroke Treatment Devices
Rivaroxaban Significantly Reduces Stroke Risk in AF Patients
Micrus Joins Codman Neurovascular
Embolization devices
Micrus Joins Codman Neurovascular
